ATC Group: R05DB Other cough suppressants

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R05DB in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R05 Cough and cold preparations
3 R05D Cough suppressants, excl. combinations with expectorants
4 R05DB Other cough suppressants

Group R05DB contents

Code Title
R05DB01 Benzonatate
R05DB02 Benproperine
R05DB03 Clobutinol
R05DB04 Isoaminile
R05DB05 Pentoxyverine
R05DB07 Oxolamine
R05DB09 Oxeladin
R05DB10 Clofedanol
R05DB11 Pipazetate
R05DB12 Bibenzonium bromide
R05DB13 Butamirate
R05DB14 Fedrilate
R05DB15 Zipeprol
R05DB16 Dibunate
R05DB17 Droxypropine
R05DB18 Prenoxdiazine
R05DB19 Dropropizine
R05DB20 Combinations
R05DB21 Cloperastine
R05DB22 Meprotixol
R05DB23 Piperidione
R05DB24 Tipepidine
R05DB25 Morclofone
R05DB26 Nepinalone
R05DB27 Levodropropizine
R05DB28 Dimethoxanate
R05DB29

Active ingredients in R05DB

Active Ingredient Description
Benproperine
Benzonatate
Butamirate

Butamirate (or brospamin) is a cough suppressant. It binds to the cough center in the medulla oblongata, more specifically the dextromethorphan-binding site in guinea pig brain with high affinity.

Clobutinol
Clofedanol

Clofedanol is a centrally-acting cough suppressant, although the mechanism of action is not known. Clofedanol suppresses the cough reflex by a direct effect on the cough center in the medulla of the brain. It also has local anesthetic and antihistamine properties, and may have anticholinergic effects at high doses.

Cloperastine

Cloperastine is an antitussive and antihistamine that is marketed as a cough suppressant. The precise mechanism of action of cloperastine is not fully clear, but several different biological activities have been identified for the drug, of which include: ligand of the gamma1 receptor (Ki = 20 nM) (likely an agonist), GIRK channel blocker (described as “potent”), antihistamine (Ki = 3.8 nM for the H1 receptor), and anticholinergic. Cloperastine possesses dual activity. It also acts as a mild bronchorelaxant and has antihistaminic activity, without acting on the central nervous system or the respiratory center.

Dropropizine
Gefapixant

Gefapixant is a selective antagonist of the P2X3 receptor. P2X3 receptors are ATP-gated ion channels found on sensory C fibres of the vagus nerve in the airways. C fibres are activated in response to inflammation or chemical irritants. Blockade of ATP signalling through P2X3 receptors reduces excessive sensory-nerve activation and excessive cough induced by extracellular ATP.

Levodropropizine

Levodropropizine is a drug provided with a mainly peripheral tracheobronchial antitussive effect together with an antiallergic and antibronchospastic effect.

Oxeladin

Oxeladin is a highly potent and effective drug used to treat all types of cough of various etiologies. It is not related to opium or its derivatives, so treatment with oxeladin is free of risk of dependence or addiction.

Oxolamine
Pentoxyverine

Pentoxyverine is a non-opioid antitussive used to prevent cough caused by common cold. It is used as an active ingredient of several oral over-the-counter cough suppressants alone or in combination with other medications, especially decongestants.

Prenoxdiazine
Tipepidine
Zipeprol

Related product monographs

Title Information Source Document Type  
BUTAMIRATE Syrup European Medicines Agency (EU) MPI, EU: SmPC
LYFNUA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
SINECOD Syrup Medicines Authority (MT) MPI, EU: SmPC